Old Covid-19 incidence rate

Description

### Actions of Public Health France Public Health France’s mission is to improve and protect the health of populations. During the health crisis linked to the COVID-19 outbreak, Santé publique France is responsible for monitoring and understanding the dynamics of the epidemic, anticipating the various scenarios and putting in place actions to prevent and limit the transmission of this virus on national territory. ### The Tracking Information System (SI-DEP) The new screening information system (SI-DEP), which has been in operation since 13 May 2020, is a secure platform where the results of the laboratory tests carried out by all city and hospital laboratories for SARS-COV2 are systematically recorded. The creation of this information system is authorised for a period of 6 months from the end of the state of health emergency by application of [Decree No 2020-551 of 12 May 2020](https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000041869923) on the information systems referred to in Article 11 of Law No 2020-546 of 11 May 2020 extending the state of health emergency and supplementing its provisions. ### Description of data This dataset provides information at the departmental and regional level: — the daily and weekly incidence rate per age group; — the daily and weekly standardised incidence rate; — the sliding standardised incidence rate. This dataset provides information at the national level: — the daily and weekly incidence rate by age group and sex; — the daily and weekly standardised incidence rate; — the sliding standardised incidence rate. The incidence rate corresponds to the number of positive tests per 100,000 inhabitants. It shall be calculated as follows: (100000 * number of positive cases)/Population **Accuracy**: — From 29/08 onwards, laboratory data indicators (SI-DEP) show rates of incidence, positivity and screening adjusted for screenings conducted at airports upon arrival of international flights. — For more information, see the methodological note available in the resources. **Limits**: — Only the biological tests of persons for whom the residence department could be located are shown on the maps. Persons whose department could not be traced in the SIDEP data are counted only at the whole French level. As a result, the sum of the tests indicated in the departments or regions is less than the number of tests indicated in France. — The time limit for repeating tests may exceed 9 days in some cases. The indicators are adjusted daily according to the receipt of the results. ### Notable changes Since 8 December, after verifying the quality of the reported data, all results of RT-PCR or Antigenic tests have been included in the production of national and territorial epidemiological indicators (incidence rates, positivity rates and screening rates) relevant to the monitoring of the COVID-19 outbreak. On the other hand, the epidemic is prolonging in time and screening capacities have increased, leading to an increasing frequency of people tested several times. Thus, an adjustment of the methods of splitting for patients benefiting from repeated tests and therefore the definition of the persons tested was necessary. Public Health France, in its patient-centred epidemiological approach, has therefore adapted its methods to ensure that these indicators reflect, in particular, the proportion of infected people among the population tested. These developments have no impact on the trends and interpretation of the dynamics of the epidemic, which remain the same. More precise test data (impact and positivity) are also published by [Santé publique France](https://www.data.gouv.fr/fr/organizations/sante-publique-france/) (SI-DEP data).

Resources

Name Format Description Link
74 https://www.data.gouv.fr/api/1/datasets/r/071f41a9-f378-44f5-8826-ed20e72d4688
54 https://www.data.gouv.fr/api/1/datasets/r/f9e0b0f6-8b54-48ee-b91b-47d5efa914a9
74 https://www.data.gouv.fr/api/1/datasets/r/cbd6477e-bda6-485d-afdc-8e61b904d771
74 https://www.data.gouv.fr/api/1/datasets/r/23066f40-ddd2-40c9-931c-4257f36ad778
74 https://www.data.gouv.fr/api/1/datasets/r/57d44bd6-c9fd-424f-9a72-7834454f9e3c
33 https://www.data.gouv.fr/api/1/datasets/r/1124cf05-f6de-41cc-9830-79c9af2e2774
74 https://www.data.gouv.fr/api/1/datasets/r/3c18e242-7d45-44f2-ac70-dee78a38ee1c
74 https://www.data.gouv.fr/api/1/datasets/r/bb2a18f3-bdd5-4101-8687-945d6e4e435f
74 https://www.data.gouv.fr/api/1/datasets/r/d9f31e19-c018-43af-a089-aaec2bbcf4cf
54 https://www.data.gouv.fr/api/1/datasets/r/4964c5d0-c7c2-48ce-967d-81bc1f14e00f
33 https://www.data.gouv.fr/api/1/datasets/r/dce002b0-0343-4864-9b39-673e3f5bb32e
74 https://www.data.gouv.fr/api/1/datasets/r/66b09e9a-41b5-4ed6-b03c-9aef93a4b559
74 https://www.data.gouv.fr/api/1/datasets/r/2360f82e-4fa4-475a-bc07-9caa206d9e32
74 https://www.data.gouv.fr/api/1/datasets/r/36ab36ea-d073-4543-9ea0-a64a0175083f
54 https://www.data.gouv.fr/api/1/datasets/r/cb8760ed-1e2d-460f-91ea-5eb82eab0920
54 https://www.data.gouv.fr/api/1/datasets/r/a4eecf68-9013-4876-a49c-bdf342105fc7
74 https://www.data.gouv.fr/api/1/datasets/r/59ad717b-b64e-4779-85f6-cd1b25b24703
54 https://www.data.gouv.fr/api/1/datasets/r/a8b5931a-3aa7-4aec-a81b-8b3de628cf63
74 https://www.data.gouv.fr/api/1/datasets/r/ad09241e-52fa-4be8-8298-e5760b43cae2
74 https://www.data.gouv.fr/api/1/datasets/r/b4c0001e-fc7e-46a8-a6c4-441f54f8e061
74 https://www.data.gouv.fr/api/1/datasets/r/19a91d64-3cd3-42fc-9943-d635491a4d76
74 https://www.data.gouv.fr/api/1/datasets/r/4180a181-a648-402b-92e4-f7574647afa6
54 https://www.data.gouv.fr/api/1/datasets/r/aa7a0f1c-89e3-4d40-af94-6f226202ada3

Tags

  • covid19
  • coronavius
  • covid-19

Topics

Categories